Skyrocketing youth use of e-cigarettes, especially Juuls, has led to several government regulations around teen vaping.
U.S. Food And Drug Administration (FDA)
Colorado is becoming an epicenter in the fight over teen vaping.
British drugmaker GW Pharmaceuticals is seeking permission to sell its medication for rare, hard-to-treat seizures in children.
The American Veterinary Medical Association wants the DEA to declassify marijuana as a Schedule 1 drug "to facilitate research opportunities."